Figure 5. Gadodiamide induced HaCaT cell apoptosis. (A) Fluorescence images of chromatin condensation in HaCaT cells after treatment with or without 13 mM gadodiamide; left: vehicle-treated control; right: 13 mM gadodiamide-treated cells. (B) Time-dependent increase of the caspase intensity by 13 mM gadodiamide treatment at 0, 12, 18, and 24 h. (C) Quantitative data for HaCaT cells treated with 13 mM gadodiamide at 0, 12, 18, and 24 h. ***Statistically significant difference from vehicle-treated control cells.
